chrisvoncsefalvay/vaers-outcomes huggingface dataset:
NOSEBLEED; STOMACH CRAMPING; HEADACHE; This spontaneous report received from a patient concerned a 27 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207a21a, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced nosebleed. On 12-APR-2021, the subject experienced stomach cramping. On 12-APR-2021, the subject experienced headache. Treatment medications (dates unspecified) included: paracetamol, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nosebleed, and stomach cramping, and had not recovered from headache. This report was non-serious.
This spontaneous report was received from a healthcare worker and refers to a patient of unknown age and gender. No information about patient's pertinent medical history, concurrent medical conditions, concomitant medications, drug reactions or allergies was provided. On an unspecified date in 2012, the patient was vaccinated with the third dose of MMR II, lot # 0873aa, expiration date 06-JUN-2013 (dose and route were not reported). No adverse experience was reported. Additional information has been requested.
It was reported that a patient received a TD Adult vaccination, date not specified. Reportedly sometime after the vaccination the patient developed "flu-like"symptoms and a local reaction, red swollen arm. Further information is requested.
Have had pain in upper arm and shoulder area, throbs at night and hurt when lifting and moving in certain directions.  Loss of strength in arm and hand and some tingling in the left hand.  Dr has ordered xray to check area and make sure nothing else and prescribed meloxicam for inflamation.
Received 4th DTaP in (R) thigh on 4/22. By 4/23 (R) thigh swollen to 2 1/2 cm > than (L) and red. By 4/24 ambulating fine, swelling down to 2cm.
high blood pressure; Extremely severe headache which is relentless; fever; A spontaneous report was received from  a health care professional concerning a 61 years male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events like  high blood pressure 160/100 ,fever and persistent headache.  The patient's medical history  provided confirms that the patient was tested positive for COVID-19 on 08 Nov 2020. The concomitant medications taken by the patients included Losartan which is used for unknown indication.  On29 Dec 2020,prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273(Batch number- unknown) for prophylaxis of COVID-19 infection.  On 26 Jan 2020,prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273(Batch number- unknown) for prophylaxis of COVID-19 infection.  On an unspecified date the patient  experienced high blood pressure 160/100,fever and persistent headache. On 12 Jan 2021 tests like CMP,CBC,C-reactive, TSH, Vitamin d were performed ath result was all normal. Treatment medications included losartan , amlodipine  and metoprolol to keep his blood pressure under control.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events headache, high blood pressure 160/100. fever and persistent headache is considered to be unknown.
Given Dtap, Hep A at well child cheek 1/7.  Screamed all night and again next night.  No fever.  No other source.
Headache at 4 pm that night but went away after 2 advil. Started with chills and body aches during the night and then fever. Took Advil with little effect. Temp went up to 38.8 by next 24 hours with continued body aches. Continued with Advil. Fever never went below 38 for next 24 hours. but then started to go down along with body aches.  Tired 3 days later temp down to normal.
30min after first shot on December 17th had numbness up my left jaw and migraine headache on both temples. Numbness to jaw lasted 5 days, migraine headache lasted till January 1st.  Second shot was on January 5th, 20 minutes after the shot left numbness to the jaw and entire cheek. Persistent sense. Headache worse than the first shot, but not vomiting because prescription phenergan and zofran.. negative covid tests since March
pemphigus vulgaris; This is a spontaneous report received from a non-contactable reporter(s) (Physician).  A patient (no qualifiers provided) received BNT162b2 (COMIRNATY), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PEMPHIGUS (medically significant), outcome "unknown", described as "pemphigus vulgaris". Clinical course: During a podium presentation a doctor described his experience with a patient developed pemphigus vulgaris 2 days after receiving the Pfizer Covid vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information provided in the narrative, a causal association between the suspect drug and the event cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Patient felt tipsy "like I was buzzed".; This spontaneous case was reported by a consumer and describes the occurrence of FEELING DRUNK (Patient felt tipsy "like I was buzzed".) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced FEELING DRUNK (Patient felt tipsy "like I was buzzed".). At the time of the report, FEELING DRUNK (Patient felt tipsy "like I was buzzed".) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported.  Patient took a nap and was fine.   This case was linked to MOD-2022-576746, MOD-2022-576759, MOD-2022-576600 (Patient Link).
Pt complained of 8/10 headache 15-20 minutes after receiving the vaccine. He stated, feeling lightheaded, nauseated, and felt like he was  "floating". RN also noticed pt's face turning red. Vital signs obtained are as follows: BP 132/81; HR 85; SPO2 95%. Pt was seen by provider and given Tylenol 325 mg for his HA. Pt was also advised to lay down and was monitored for 30 minutes. Public Health provider recommended pt to be seen by patient's HCP.
Post vax, pt developed fever of 102 for 4 days. He also had a sore arm, malaise, nausea, and weakness for 4 weeks. Treated with APAP and fluids.
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Body Aches Generalized-Severe, Systemic: Confusion-Mild, Systemic: Fever-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Joint Pain-Severe, Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial area, extemities)-Mild, Systemic: Weakness-Medium, Additional Details: Started with pain left arm,swelling and rash. A week later had pain in right knee,moved to right hip then moved to right foot. Toes in both feet numb. Patient had to walk with a cain for a couple of weeks.
mild rash on stomach areas; small bumps; This case was reported by a other health professional via (Shingrix GSK and described the occurrence of rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In March 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced rash and papular rash. On an unknown date, the outcome of the rash and papular rash were unknown.   It was unknown if the reporter considered the rash and papular rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix shot and she got a mild rash on stomach areas and small bumps. The patient is now due for the 2nd dose. The patient was worried about a more severe reaction should she take it. The follow up would not be possible as no contact details were available.
Patient stated her hold right side was swollen. Patient came in for 3rd dose and told the doctor what happen on 3/12/2010.
pt vax hepta B on 09oct89, 08apr90, and 09apr90. pt also donated blood on 23oct89, 29dec89, and 13mar90. pt sgpt was 75 on 23oct89 and 69 on 08dec89.  sgpt level was also elevated approx. 1-2 weeks follwing 3rd vax.
Slight numbness at injection site and down lower arm.  Woke up in middle of night with numbness in lower arm. Acute sinus condition at bedtime, congestion and sneezing for about two hours.  Took two Benadryl tablets.
Headache, Myalgia, Rigors, fevers, and frontal headaches Narrative: 12 hours after vaccine given, experienced severe, extreme rigors, along with fevers to 103.2, unresponsive to acetaminophen and ibuprofen. Also reported intractable headache (mostly frontal). 24 hours later, temperature reported as normal. Of note, reports history of mild COVID before (positive PCR 11/2020 with symptoms but never severe).
Feeling sick; it was my back bothering me; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old female patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 30Mar2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 68 years intramuscular, in arm for immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Flu shot (Any prior vaccination: Consumer stated, "I got a Flu shot a couple of years ago."), for Immunization. The following information was reported: MALAISE (non-serious) with onset 31Mar2023, outcome "unknown", described as "Feeling sick"; BACK DISORDER (non-serious) with onset 31Mar2023, outcome "unknown", described as "it was my back bothering me". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of malaise, back disorder. Additional information included: the patient reported that last she received Prevnar 20 this Thursday 30Mar and the next day she began feeling so sick, really sick. The patient just notice that it was her back bothering her then the day after that morning she looked up, she had been just pick up the dog, she was good. He did all blood work for her. Lab test on of 30Mar2023. Lab details were not available. The patient did Ibuprofen, she took Ibuprofen 200 milligrams and she took two of them. The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.
Low grade fever, bulging fontanelle requiring hospital admission for observation. Immunizations were given the day prior to admission.
Lump developed at site of injection last year, present all year. 1 month ago another lump developed near initial lump. Hard immobile.
Had Tdap at health department in afternoon and then noticed dry throat that evening that progressed to swelling of throat and hoarseness.  No temperature, no sinus drainage.  Coughing with speak.  Slight joint discomfort.  Stayed home 05/12/2006 from work because of coughing and hoarseness.
Information has been received from a medical assistant (MA), concerning her 2 month old son with no allergies with a history of premature birth and respiratory distress who on 27-SEP-2006, was vaccinated with the first dose of PEDVAXHIB. On 10-NOV-2007, the patient was vaccinated with the second dose of PEDVAXHIB and on 07-AUG-2007, was vaccinated with the third dose of PEDVAXHIB. Concomitant therapy included vitamins, unspecified, XOPENEX and "PULLMICORT". The MA reported that her son experienced respiratory distress with cyanosis within one hour of each dose of PEDVAXHIB on 27-SEP-2006, 10-NOV-2006 and 07-AUG-2007. On 27-SEP-2006, the MA transported her son to the physician's office but no therapy was recommended. The respiratory symptoms recurred on 10-NOV-2006, after the second dose of PEDVAXHIB, and the patient was transported to the local emergency room. The MA stated no therapy was prescribed. The patient received a third dose of PEDVAXHIB on 07-AUG-2007, and experienced immediate cyanosis, bilateral cervical lymph node swelling, vomiting and diarrhea. The patient was transported to the local emergency room but the MA was unable to recall if treatment was provided at that time. The patient experienced a cyanotic episode on 10-SEP-2007, and was hospitalized. A chest x-ray revealed pneumonia and a lung biopsy on 13-SEP-2007 revealed haemophilus influenzae type b. The patient was started on oral antibiotics and discharged on 16-SEP-2007. The patient was recovering and was now taking, XOPENEX and "PULMICORT" as needed. No further details were available. The reporter considered respiratory distress with cyanosis, bilateral cervical lymph node swelling, vomiting and diarrhea, pneumonia and haemophilus influenzae type b as other important medical events. Additional information has been requested.
I started having symptoms on 5/12/22 with sore throat, headaches, so that is why I took a home test and it was positive and took another in 8 hrs. and it was positive as well. My symptoms lasted for 5 days and I been symptom free that last 2 days.
After shot, I had swelling of lips, hives on neck and arms, and red marks on hands. This was about 5 minutes after shot.  Next day I had chills, nausea, headache, sore throat, and  shakes. Started the afternoon of the next day.  My arm has been red and itchy since the day, but it is increasing becoming warmed, bigger, and itchier every day since.
tingling and numbness at the tip of my tongue, headache, and food taste sweet or spicy such as bananas and ice cream taste very sugary and fries taste peppery and some foods don't have any taste. 20 minutes after vaccine my tongue felt swollen and under my chin felt swollen. Swelling was mild and went away after an hour or 2.
chest pain; fever; chills; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent. Other Case identifier 20211258418.  A 18 year-old male patient received bnt162b2 (BNT162B2), administration date 19Apr2021 (Lot number: FW0161) at the age of 18 years as dose 1, single and administration date 19May2021 (Lot number: ER8736) as dose 2, single for covid-19 immunisation; covid-19 vaccine janssen (COVID-19 VACCINE JANSSEN), administered in deltoid left, administration date 24Dec2021 (Lot number: 1855191, Expiration Date: 11Apr2022) as dose 3 (booster), single for immunisation. Relevant medical history included: "Interchange of vaccine products" (unspecified if ongoing). Concomitant medication(s) included: NAPROSYN [NAPROXEN]. The following information was reported: CHEST PAIN (non-serious) with onset 24Dec2021, outcome "recovering", described as "chest pain"; PYREXIA (non-serious) with onset 24Dec2021, outcome "recovered", described as "fever"; CHILLS (non-serious) with onset 24Dec2021, outcome "recovered" (25Dec2021), described as "chills". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of chest pain, pyrexia, chills.  Additional information: The patient previously received non-company bnt 162 vaccine (dose number in series was 1) (form of admin, route of admin not reported, batch number: ER8736) dose was not reported, administered on 19May2021 for prophylactic vaccination. On an unspecified date, the patient experienced chest pain following vaccination with non-company bnt 162 vaccine (dose number in series was 1). The patient received covid-19 vaccine ad26.cov2. s (dose number in series was 2) (suspension for injection, route of admin not reported, batch number: 1855191 expiry: 11Apr2022) dose was not reported, 1 total, administered on 24Dec2021 to Left Deltoid for prophylactic vaccination. Concomitant medications included naproxen. On 24Dec2021, within 6 hours from vaccination, the patient experienced fever, chest pain and chills following vaccination with covid-19 vaccine ad26.cov2. s (dose number in series was 2). The patient received treatment with Aleve. Patient's chest pain symptom was faded. Patient's health care professional (HCP) suspected that the vaccination causeed chest pain. Patient did not go to emergency room (ER).  For chest pain, chills and fever causality as per reporter and manufacturer was possible.   No follow-up attempts are possible. No further information is expected.
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 18-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant No Treatment medications were reported.
my head feels like it will explode; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (my head feels like it will explode) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (my head feels like it will explode). At the time of the report, HEAD DISCOMFORT (my head feels like it will explode) outcome was unknown.            Concomitant medications were not provided.  Treatment information was not provided.
pt recv vax 17MAR99 & 10min later pt devel paresthesia, severe arthralgia & hollow chest feeling;pt exp uncontrollable shaking w/in12min, became hypertensive & was treated in ER as if for anaphylaxis w/epi w/o steroids;pt observed 2 1/2hr;
pt devel aplastic anemia about 1mo p/vax;this case was reported by a pharmacist;
pt c/o eyes feeling "grainy" eyelids swelled sl 40min post vax;epi given & sx subsided immed;
J&J dose received on 5/5/21 prior to admission to this facility on 12/14/21.  Resident representative  signed consent on 12/14/21 for J&J Booster to be received.  Medical Director approved booster.  Booster given on 12/15/21.  Resident passed away 12/17/21 @ 11:44am.
Fluarix exposed to freezing temperature was administrated; This case was reported by a other health professional and described the occurrence of incorrect storage of drug in a 31-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) (batch number LZ4N2, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 11th October 2021, the patient received Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details provided were as follows: The health care professional called and reported that a Fluarix QIV that was exposed to freezing temperature was administrated to a patient, which led to incorrect storage of drug. No symptoms or further details were reported. The reporter agreed to follow-up. This case was 1 of 8 case reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR215096:different patient, same reporter US-GLAXOSMITHKLINE-US2021AMR215097:different patient, same reporter US-GLAXOSMITHKLINE-US2021214412:different patient, same reporter US-GLAXOSMITHKLINE-US2021AMR215094:different patient, same reporter US-GLAXOSMITHKLINE-US2021AMR215098:different patient, same reporter US-GLAXOSMITHKLINE-US2021AMR215092:different patient, same reporter US-GLAXOSMITHKLINE-US2021AMR215093:different patient, same reporter
Household contacts had covid 4/15/21 (PCR+) when pt had cough/fatigue.  He got 1st Pfizer dose 5/11/21. 5/24 he develops abdl pain, nausea, vomitting; seen in ED 5/28 w/ WBC cnt 17k CRP 197 but neg CT abdomen.  Our ED on 5/31hypotensive, temp 101.8, pulse 130s, COVID PCR neg, CXR normal. Despite fluids, needed pressors.  Next day, still on pressors, new CHF,  pulmonary opacities on XR, Echo with severe biventricular hypokinesis(EF 20%).  Inflamm markers elevated:  WBC 19k , 92% polys, hgb 11, plts 73k, CRP 334 mg/L, COVID spike Ab 1568, COVID NP index 233. Rx with IVIg for MIS x 1 dose, steroids, rapidly improved. On 6/11, 6/24 EF 60%, inflamm markers, CBC normalized.  Now well, off steroids.  MIS likely due to vac
This spontaneous case reported by a pharmacist, describes the occurrence of throat irritation (itchy throat) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Apr 17, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 17, 2021, patient experienced throat irritation (itchy throat). The patient treated with Benadryl (diphenhydramine hydrochloride); 1 dosage form. On Apr 17, 2021, throat irritation (itchy throat) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The reporter did not provide any causality assessments. No concomitant medication reported.
Fainted for 2 minutes, sweat, turned pale, low heart rate.. the called 911 patient given IV by paramedics.
Dizziness/Vertigo; Nausea; Headaches; Blurry Vision; Unable to concentrate; Tinnitus (very low); Fullness and pain in ear
Fridge temperature went out of range by 4 degrees overnight Sunday due to storm, health department closed on 1/17/2022. Vaccines administered to patients in the morning.